Solvonis Therapeutics (SVNS)

Sector:

Pharma and Biotech

 0.15p
   
  • Change Today:
      0.000p
  • 52 Week High: 0.39p
  • 52 Week Low: 0.12p
  • Currency: UK Pounds
  • Shares Issued: 6,806m
  • Volume: 13,749,594
  • Market Cap: £10.21m
  • Beta: 0.02

Latest ShareCast News

SVN-114 selected for PTSD discovery programme

By Sharecast

Date: Tuesday 10 Mar 2026

Research and Development Update – Q4 2025

By Sharecast

Date: Monday 22 Dec 2025

Graft Polymer to buy Awakn in £4.98m deal

By Michele Maatouk

Date: Monday 16 Dec 2024

(Sharecast News) - Biotech firm Graft Polymer said on Monday that it has agreed to buy Awakn Life Sciences Corp, a clinical-stage biotechnology company developing therapeutics for substance use and mental health disorders, for £4.98m.

No recent information was found.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

SVNS Market Data

Currency UK Pounds
Share Price 0.15p
Change Today 0.000p
% Change 0.00 %
52 Week High 0.39p
52 Week Low 0.12p
Volume 13,749,594
Shares Issued 6,806m
Market Cap £10.21m
Beta 0.02

SVNS Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
44.84% below the market average44.84% below the market average44.84% below the market average44.84% below the market average44.84% below the market average
2.44% above the sector average2.44% above the sector average2.44% above the sector average2.44% above the sector average2.44% above the sector average
Price Trend
35.55% above the market average35.55% above the market average35.55% above the market average35.55% above the market average35.55% above the market average
40.91% above the sector average40.91% above the sector average40.91% above the sector average40.91% above the sector average40.91% above the sector average
Income Not Available
Growth Not Available

SVNS Dividends

No dividends found

Trades for 19-Aug-2026

Time Volume / Share Price
16:35 28,015 @ 0.15p
16:35 28,015 @ 0.15p
16:24 141,028 @ 0.14p
14:52 3,106 @ 0.16p
14:52 30,461 @ 0.14p

SVNS Key Personnel

CEO Anthony Tennyson
Chair Dennis Purcell

Top of Page